Table 2 Treatment status by age and stage.
By age | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Years | Supportive care | Surgical resection | RFA | TACE | Chemotherapy | Radiation therapy | Radioembolization | Transplantation | Total | ||||||||
n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | ||
65–70 | 179 | (15.84) | 263 | (23.27) | 152 | (13.45) | 456 | (40.35) | 54 | (4.78) | 15 | (1.33) | 3 | (0.27) | 8 | (0.71) | 1130 |
70–75 | 214 | (20.48) | 191 | (18.28) | 118 | (11.29) | 461 | (44.11) | 47 | (4.50) | 7 | (0.67) | 6 | (0.57) | 1 | (0.10) | 1045 |
75–80 | 249 | (31.28) | 80 | (10.05) | 88 | (11.06) | 319 | (40.08) | 47 | (5.90) | 9 | (1.13) | 4 | (0.50) | 0 | (0.00) | 796 |
80–85 | 157 | (40.05) | 27 | (6.89) | 23 | (5.87) | 155 | (39.54) | 22 | (5.61) | 4 | (1.02) | 4 | (1.02) | 0 | (0.00) | 392 |
 ≥ 85 | 69 | (53.49) | 2 | (1.55) | 6 | (4.65) | 40 | (31.01) | 6 | (4.65) | 3 | (2.33) | 3 | (2.33) | 0 | (0.00) | 129 |
Total | 868 | (24.86) | 563 | (16.12) | 387 | (11.08) | 1431 | (40.98) | 176 | (5.04) | 38 | (1.09) | 20 | (0.57) | 9 | (0.26) | 3492 |
By tumor stage | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
mUICC stage | Supportive care | Surgical resection | RFA | TACE | Chemotherapy | Radiation therapy | Radioembolization | Transplantation | Total | ||||||||
n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | ||
I | 38 | (8.32) | 56 | (12.25) | 178 | (38.95) | 177 | (38.73) | 0 | (0.00) | 5 | (1.09) | 1 | (0.22) | 2 | (0.44) | 457 |
II | 217 | (15.48) | 404 | (28.82) | 168 | (11.98) | 568 | (40.51) | 20 | (1.43) | 9 | (0.64) | 14 | (1.00) | 2 | (0.14) | 1402 |
III | 270 | (27.49) | 91 | (9.27) | 34 | (3.46) | 524 | (53.36) | 45 | (4.58) | 8 | (0.81) | 5 | (0.51) | 5 | (0.51) | 982 |
IV-A | 162 | (48.07) | 9 | (2.67) | 5 | (1.48) | 112 | (33.23) | 44 | (13.06) | 5 | (1.48) | 0 | (0.00) | 0 | (0.00) | 337 |
IV-B | 177 | (57.28) | 3 | (0.97) | 2 | (0.65) | 49 | (15.86) | 67 | (21.68) | 11 | (3.56) | 0 | (0.00) | 0 | (0.00) | 309 |
Unknown | 4 | (80.00) | 0 | (0.00) | 0 | (0.00) | 1 | (20.00) | 0 | (0.00) | 0 | (0.00) | 0 | (0.00) | 0 | (0.00) | 5 |
BCLC stage | Supportive care | Surgical resection | RFA | TACE | Chemotherapy | Radiation therapy | Radioembolization | Transplantation | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | ||
Stage 0 | 12 | (5.69) | 24 | (11.37) | 93 | (44.08) | 82 | (38.86) | 0 | (0.00) | 0 | (0.00) | 0 | (0.00) | 0 | (0.00) | 211 |
Stage A | 40 | (5.41) | 218 | (29.46) | 150 | (20.27) | 322 | (43.51) | 4 | (0.54) | 4 | (0.54) | 2 | (0.27) | 0 | (0.00) | 740 |
Stage B | 151 | (23.56) | 131 | (20.44) | 6 | (0.94) | 315 | (49.14) | 18 | (2.81) | 5 | (0.78) | 12 | (1.87) | 3 | (0.47) | 641 |
Stage C | 388 | (33.62) | 104 | (9.01) | 61 | (5.29) | 436 | (37.78) | 139 | (12.05) | 24 | (2.08) | 2 | (0.17) | 0 | (0.00) | 1154 |
Stage D | 153 | (69.86) | 2 | (0.91) | 7 | (3.20) | 47 | (21.46) | 5 | (2.28) | 1 | (0.46) | 0 | (0.00) | 4 | (1.83) | 219 |
Unknown | 124 | (23.53) | 84 | (15.94) | 70 | (13.28) | 229 | (43.45) | 10 | (1.90) | 4 | (0.76) | 4 | (0.76) | 2 | (0.38) | 527 |
